Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
5
×
life sciences
national
national blog main
5
×
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
5
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
cancer immunotherapy
europe blog main
europe top stories
fda
investing
merck
philadelphia blog main
philadelphia top stories
amag pharmaceuticals
What
bio
roundup
develop
amid
bombast
buy
cancer
caught
coronavirus
debate
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
acquisitions
alliance
bails
biggest
brand
bridgebio
bristol
build
calls
capital
car
ceo
changing
color
company’s
crispr
daniel
days
Language
unset
5
×
Current search:
unset
×
startups
×
" national blog main "
×
" indiana top stories "
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More